5W5O
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.3 |
Synchrotron site | ALS |
Beamline | 5.0.3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-10-29 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9765 |
Spacegroup name | P 1 |
Unit cell lengths | 80.308, 107.475, 210.193 |
Unit cell angles | 90.15, 89.77, 89.96 |
Refinement procedure
Resolution | 47.900 - 2.890 |
R-factor | 0.2191 |
Rwork | 0.217 |
R-free | 0.25220 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | unpublished structure |
RMSD bond length | 0.010 |
RMSD bond angle | 1.120 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.5) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.000 | 3.000 |
High resolution limit [Å] | 2.890 | 2.890 |
Rmerge | 0.110 | |
Number of reflections | 138963 | 10631 |
<I/σ(I)> | 6.3 | |
Completeness [%] | 89.0 | 76 |
Redundancy | 2.1 | 1.9 |
CC(1/2) | 0.238 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 293 | 1.0M lithium chloride, 10.0% polyethylene glycol 6000, 0.1M TRIS pH 8.0 |